Hexarelin vs Ipamorelin
Research Verdict
Ipamorelin is the stronger research reference for the stated comparison criteria. Ipamorelin: Phase 2 post-operative ileus data, demonstrated selectivity - no cortisol/prolactin effects.
Quick Answers
Which is better, Hexarelin or Ipamorelin?
Ipamorelin is the stronger research reference for the stated comparison criteria. Ipamorelin: Phase 2 post-operative ileus data, demonstrated selectivity - no cortisol/prolactin effects.
What is the key difference between Hexarelin and Ipamorelin?
Ipamorelin releases GH without affecting cortisol, prolactin, or LH; hexarelin releases cortisol and prolactin alongside GH but has unique CD36-mediated cardiac effects - selectivity vs. cardiovascular pharmacology.
Evidence Comparison
Ipamorelin: Phase 2 post-operative ileus data, demonstrated selectivity - no cortisol/prolactin effects. Hexarelin: comparable GH potency, but additionally binds CD36 with cardiovascular research interest (Bodart 2002). Ipamorelin has better clinical trial infrastructure; hexarelin has the broader pharmacological profile.
Evidence Context Favoring Hexarelin
Cardiovascular research exploring CD36-mediated cardioprotection alongside GH secretion.
Evidence Context Favoring Ipamorelin
GH research requiring maximal hormonal selectivity with no cortisol, prolactin, or LH confounding.
Side-by-Side Snapshot
| Evidence grade | Hexarelin: Level C Ipamorelin: Level B |
|---|---|
| Research status | Hexarelin: Phase 2 Ipamorelin: Phase 2 |
| Primary category | Hexarelin: Growth Hormone Ipamorelin: Growth Hormone |
| Cited studies | Hexarelin: 2 Ipamorelin: 3 |